CD4+ CD25+ CD62+ T-Regulatory Cell Subset Has Optimal Suppressive and Proliferative Potential

American Journal of Transplantation

Volumn 4, Issue 1, 2004, Pages 65-78

  Fu, Shuang ^a   Yopp, Adam C ^a   Mao, Xia ^b   Chen, Dongmei ^a   Zhang, Nan ^a   Chen, Dan ^a   Mao, Minwei ^a   Ding, Yaozhong ^a   Bromberg, Jonathan S ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b New York Presbyterian Columbia University Medical Center   (United States)

Author keywords

CD4+ CD25+ Treg; L selectin; Suppression

Indexed keywords

CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR7; FINGOLIMOD; INTERLEUKIN 2 RECEPTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; PADGEM PROTEIN;

ANIMAL CELL; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CELL CULTURE; COLITIS; CONTROLLED STUDY; GASTRITIS; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE MIGRATION; LYMPHOCYTE PROLIFERATION; LYMPHOID ORGAN; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TRANSPLANTATION;

ANIMALS; ANTIGENS, CD4; CD4-POSITIVE T-LYMPHOCYTES; CELL DIVISION; CELL MOVEMENT; CELL SEPARATION; CHEMOKINE CCL2; CHEMOKINES, CC; CHEMOTAXIS; COLITIS; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GASTRITIS; L-SELECTIN; LYMPHOCYTE SUBSETS; LYMPHOCYTES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, SCID; PHENOTYPE; PROPYLENE GLYCOLS; RECEPTORS, CHEMOKINE; RECEPTORS, INTERLEUKIN-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPHINGOSINE; T-LYMPHOCYTES; TIME FACTORS;

EID: 0742284032     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1600-6143.2003.00293.x     Document Type: Article

References (69)

1. + T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J Exp Med 2001; 193: 1295-1302.
2. Jonuleit H, Schmitt E, Stassen M, Tuettenberg A, Knop J, Enk AH. Identification and functional characterization of human CD4 (+) CD25 (+) T cells with regulatory properties isolated from peripheral blood. J Exp Med 2001; 193: 1285-1294.
3. Taylor PA, Noelle RJ, Blazar BR. CD4 (+) CD25 (+) immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade. J Exp Med 2001; 193: 1311-1318.
4. Hara M, Kinglsey CI, Niimi S et al. IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J Immunol 2001; 166: 3789-3796.
5. + regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses. J Immunol 2002; 168: 1080-1086.
6. Roncarolo MG, Levings MK. The role of different subsets of T regulatory cells in controlling autoimmunity. Curr Opin Immunol 2000; 12: 676-683.
7. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995; 155: 1151-1164.
8. + naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J Immunol 1999; 162: 5317-5326.
9. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 1998; 188: 287-296.
10. + naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int Immunol 1988; 10: 1969-1980.
11. + immunoregulatory T cells is antigen nonspecific. J. Immunol 2000; 164: 183-190.
12. + T cells with regulatory properties from human blood. J Exp Med 2001; 193: 1303-1310.
13. Stephens LA, Mottet C, Mason D, Powrie F. Human CD4 (+) CD25 (+) thymocytes and peripheral T cells have immune suppressive activity in vitro. Eur J Immunol 2001; 31: 1247-1254.
14. + cells: a naturally occurring population of regulatory T cells. Blood 2001; 98: 2736-2744.
15. + regulatory cells in human peripheral blood. J. Immunol 2001; 167: 1245-1253.
16. + immunoregulatory T cells in the induction of autoimmune gastritis. Immunol Cell Biol 2002; 80: 567-573.
17. Singh B, Read S, Asseman C, et al. Control of intestinal inflammation by regulatory T cells. Immunol Rev 2001; 182: 190-200.
18. + immunoregulatory T cells that control autoimmune diabetes. Immunity 2000; 12: 431-440.
19. Green EA, Choi Y, Flavell RA. Pancreatic lymph node-derived CD4 (+) CD25 (+) Treg cells: highly potent regulators of diabetes that require TRANCE-RANK signals. Immunity 2002; 16: 183-191.
20. Cohen JL, Trenado A, Vasey D, Klatzmann D, Salomon BL. CD4(+) CD25 (+) immunoregulatory T cells: new therapeutics for graft-versus-host disease. J Exp Medical 2002; 196: 401-406.
21. Taylor PA, Lees CJ, Blazar BR. The infusion of ex vivo activated and expanded CD4 (+) CD25 (+) immune regulatory cells inhibits graft-versus-host disease lethality. Blood 2002; 99: 3493-3499.
22. Hoffmann P, Ermann J, Edinger M, Fathman CG, Strober S. Donor-type CD4 (+) CD25 (+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation. J Exp Med 2002; 196: 389-399.
23. Gallatin WM, Weissman IL, Butcher EC. A cell-surface molecule involved in organ-specific homing of lymphocytes. Nature 1983; 304: 30-34.
24. Siegelman MH, Cheng IC, Weissman IL, Wakeland EK. The mouse lymph node homing receptor is identical with the lymphocyte cell surface marker Ly-22: role of the EGF domain in endothelial binding. Cell 1990; 61: 611-622.
25. Iwabuchi K, Ohgama J, Ogasawara K, et al. Distribution of MEL-14+ cells in various lymphoid tissues. Immunobiology 1991; 182: 161-173.
26. Lewinsohn DM, Bargatze RF, Butcher EC. Leukocyte-endothelial cell recognition: evidence of a common molecular mechanism shared by neutrophils, lymphocytes, and other leukocytes. J Immunol 1987; 138: 4313-4321.
27. Jung TM, Gallatin WM, Weissman IL, Dailey MO. Downregulation of homing receptors after T cell activation. J Immunol 1988; 141: 4110-4117.
28. Sprent J, Tough DF. Lymphocyte life-span and memory. Science 1994; 265: 1395-1400.
29. Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999; 401: 708-712.
30. Sallusto F, Kremer E, Palermo B, et al. Switch in chemokine receptor expression upon TCR stimulation reveals novel homing potential for recently activated T cells. Eur J Immunol 1999; 29: 2037-2045.
31. Mackay CR, von Andrian UH. Immunology: memory T cells: local heroes in the struggle for immunity. Science 2001; 291: 2323-2324.
32. Masopust D, Vezys V, Marzo AL, Lefrancois L. Preferential localization of effector memory cells in nonlymphoid tissue. Science 2001; 291: 2413-2417.
33. + thymocytes expressing 1-selectin mediate 'active tolerance' in the nonobese diabetic mouse. J Immunol 1998; 161: 2620-2628.
34. + T cells that prevent diabetes onset in nonobese diabetic mice. J Immunol 2000; 164: 240-247.
35. Yamamoto AM, Chernajovsky Y, Lepault F et al. The activity of immunoregulatory T cells mediating active tolerance is potentiated in nonobese diabetic mice by an IL-4-based retroviral gene therapy. J Immunol 2001; 166: 4973-4980.
36. + splenocytes that delays adoptive transfer of diabetes expresses 1-selectin and high levels of CCR7. J Immunol 2002; 169: 2461-2465.
37. Spencer D, Di Marco F, Hooley J et al. The orphan receptor CRF2-4 is an essential subunit of the interleukin 10 receptor. J Exp Med 1998; 187: 571-578.
38. Brinkmann V, Pinschewer DD, Feng L, Chen S. FTY720: altered lymphocyte traffic results in allograft protection. Transplantation 2001; 72: 764-769.
39. + regulatory cells that control intestinal inflammation. J Exp Med 2000; 192: 295-302.
40. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003; 299: 1057-1061.
41. + regulatory T cells. Nat Immunol 2003; 4: 330-336.
42. + T regulatory cells. Nat Immunol 2003; 4: 337-342.
43. Papiernik M, de Moraes ML, Pontoux C, Vasseur F, Penit C. Regulatory CD4 T cells: expression of IL-2R alpha chain, resistance to clonal deletion and IL-2 dependency. Int Immunol 1998; 10: 371-378.
44. Nakamura K, Kitani A, Strober W. Cell contact-dependent immunosuppression by CD4 (+) CD25 (+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J Exp Med 2001; 194: 629-644.
45. Asseman C, Mauze S, Leach MW, Coffman RL, Powrie F. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J Exp Med 1999; 190: 995-1004.
46. + T cells. J Exp Med 1996; 183: 2669-2674.
47. Kotenko SV, Izotova LS, Mirochnitchenko OV et al. Identification of the functional interleukin-22 (IL-22) receptor complex: the IL-10R2 chain (IL-10Rbeta) is a common chain of both the IL-10 and IL@-22 (IL-10-related T cell-derived inducible factor, IL-TIF) receptor complexes. J Biol Chem 2001; 276: 2725-2732.
48. Sheppard P, Kindsvogel W, Xu W et al. IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat Immunol 2003; 4: 63-68.
49. Levings MK, Sangregorio R, Sartirana C, et al. Human CD25 (+) CD4 (+) T Suppressor Cell Clones Produce Transforming Growth Factor beta, but not Interleukin 10, and Are Distinct from Type 1 T Regulatory Cells. J Exp Med 2002; 196: 1335-1346.
50. Chen Y, Kuchroo VK, Inobe J, Hafler DA, Weiner HL. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 1994; 265: 1237-1240.
51. Chen Y, Inobe J, Kuchroo VK, Baron JL, Janeway CA Jr, Weiner H. Oral tolerance in myelin basic protein T-cell receptor transgenic mice: suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells. Proc Natl Acad Sci U S A 1996; 93: 388-391.
52. Roncarolo MG, Bacchetta R, Bordignon C, Narula S, Levings MK. Type 1 T regulatory cells. Immunol Rev 2001; 182: 68-79.
53. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997; 389: 737-742.
54. Gavin MA, Clarke SR, Negrou E, Gallegos A, Rudensky A. Homeostasis and anergy of CD4 (+) CD25 (+) suppressor T cells in vivo. Nat Immunol 2002; 3: 33-41.
55. Iellem A, Mariani M, Lang R et al. Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4 (+) CD25 (+) regulatory T cells. J Exp Med 2001; 194: 847-853.
56. + T cells represent major subsets of human peripheral blood memory T cells migrating in response to CCL1/I-309. Eur J Immunol 2002; 32: 3506-3514.
57. Honig SM, Fu S, Mao X, et al. FTY720 stimulates multidrug transporter and cysteinyl leukotriene dependent T cell chemotaxis to lymph nodes. J Clin Invest 2003; 111: 627-637.
58. Henning G, Ohl L, Junt T et al. CC chemokine receptor 7-dependent and - independent pathways for lymphocyte homing: modulation by FTY720. J Exp Med 2001; 1: 1875-1881.
59. Chen S, Bacon KB, Garcia G et al. FTY720, a novel transplantation drug, modulates lymphocyte migratory responses to chemokines. Transplant Proc 2001; 33: 3057-3063.
60. Kuniyasu Y, Takahashi T, Itoh M, Shimizu J, Toda G, Sakaguchi S. Naturally anergic and suppressive CD25 (+) CD4 (+) T cells as a functionally and phenotypically distinct immunoregulatory T cell subpopulation. Int Immunol 2000; 12: 1145-1155.
61. Papiernik M, do Carmo Leite-de-Moraes M, Pontoux C et al. T cell deletion induced by chronic infection with mouse mammary tumor virus spares a CD25-positive, IL-10-producing T cell population with infectious capacity. J Immunol 1997; 158: 4642-4653.
62. + T cells regulate the expansion of peripheral CD4 T cells through the production of IL-10. J Immunol 2001; 166: 3008-3018.
63. + T (R) cells suppress innate immune pathology through cytokine-dependent mechanisms. J Exp Med 2003; 197: 111-119.
64. Piccirillo CA, Letterio JJ, Thornton AM et al. CD4 (+) CD25 (+) regulatory T cells can mediate suppressor function in the absence of transforming growth factor beta1 production and responsiveness. J Exp Med 2002; 196: 237-246.
65. Takahashi T, Tagami S, Yamazaki S et al. Immunologic self-tolerance maintained by CD25 (+) CD4 (+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J Exp Med 2000; 192: 303-310.
66. Read S, Malmstrom V, Powrie F. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25 (+) CD4 (+) regulatory cells that control intestinal inflammation. J Exp Med 2000; 192: 295-302.
67. + T cells as immunoregulatory T cells in vitro. Eur J Immunol 2002; 32: 2365-2375.
68. Cyster JG. Chemokines and cell migration in secondary lymphoid organs. Science 1999; 286: 2098-2102.
69. Bystry RS, Aluvihare V, Welch KA, Kallikourdis M, Betz AG. B cells and professional APCs recruit regulatory T cells via CCL4. Nat Immunol 2001; 2: 1126-1132.